Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 25 von 38
ANZ journal of surgery, 2024-04, Vol.94 (4), p.674-683
2024

Details

Autor(en) / Beteiligte
Titel
Impact of the COVID‐19 pandemic on outcomes of cholecystectomy for acute cholecystitis: a national cohort study
Ist Teil von
  • ANZ journal of surgery, 2024-04, Vol.94 (4), p.674-683
Ort / Verlag
Melbourne: John Wiley & Sons Australia, Ltd
Erscheinungsjahr
2024
Link zum Volltext
Quelle
Wiley-Blackwell Journals
Beschreibungen/Notizen
  • Background The COVID‐19 pandemic was associated with significant disruptions to healthcare provision globally and in Aotearoa New Zealand. It remains unclear how this disruption affected the surgical management of acute cholecystitis and whether there are ongoing impacts. Methods We conducted a secondary analysis of two multicentre cohort studies (CHOLECOVID and CHOLENZ) on patients who underwent cholecystectomy for acute cholecystitis. Participants were categorized into pre‐pandemic (September–November 2019), pandemic (March–May 2020), and late‐pandemic (August–October 2021) phases. Baseline demographics, clinical management, and 30‐day postoperative complications were assessed between phases. Multivariable logistic regression was used to explore the impact of timing of operation on rates of hospital readmission and postoperative complications. Results 517 participants were included, of whom 85 (16%) were in the pre‐pandemic‐phase, 52 (10%) were in the pandemic phase, and 380 (73%) were in the late‐pandemic phase. Pandemic and late‐pandemic phase participants were more comorbid and had higher rates of obesity and deranged blood results than pre‐pandemic. After multivariable adjustment, there were no differences in rates of hospital readmission or postoperative complications at 30‐day follow‐up across phases. Conclusion The COVID‐19 pandemic had minimal impacts on the provision of cholecystectomy for acute cholecystitis in Aotearoa New Zealand. However, patients managed during the COVID‐19 pandemic were more comorbid and had higher rates of obesity and elevated inflammatory markers. We found that the surgical management of acute cholecystitis through cholecystectomy had minimal disruptions over pre‐pandemic, pandemic, and late‐pandemic phases, but identify key differences in rates of comorbidity and disease severity. We also report novel sub‐analyses exploring the impact of ethnicity.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX